Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 mai 2026 17h28 HE | Source: Schall Law

IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm
07 mai 2026 09h39 HE | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Immutep Limited Investors

LOS ANGELES, May 07, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Immutep Limited, (“Immutep” or the "Company") (NASDAQ: IMMP) investors of a class action on behalf of investors that bought...
07 mai 2026 09h03 HE | Source: Bernstein Liebhard LLP

IMMUTEP LIMITED (IMMP) INVESTOR ALERT Investors With Large Losses in Immutep Limited Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Immutep Shareholders Between March 24, 2025 and March 12, 2026 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
07 avr. 2021 08h00 HE | Source: Immutep Limited

Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy

Sydney, AUSTRALIA, April 07, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for...